Search Results - "De Miguel Llorente, Dunia"

Clinical outcomes after CPX‐351 in patients with high‐risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry by Bernal, Teresa, Moreno, Ainhoa Fernández, de LaIglesia, Almudena, Benavente, Celina, García‐Noblejas, Ana, Belmonte, Daniel García, Riaza, Rosalía, Salamero, Olga, Foncillas, Maria Angeles, Roldán, Alicia, Concepción, Víctor Noriega, González, Laura Llorente, Bergua Burgués, Juan Miguel, Lorente de Uña, Soraya, Rodríguez‐Macías, Gabriela, de la Fuente Burguera, Adolfo, García Pérez, Maria José, López‐Lorenzo, Jose Luis, Martínez, Pilar, Aláez, Concepción, Callejas, Marta, Martínez‐Chamorro, Carmen, Roca, José Rifón, Barciela, Lourdes Amador, Mena Durán, Armando V., Gómez Correcha, Karoll, Lavilla Rubira, Esperanza, Amigo, María Luz, Vall‐llovera, Ferran, Garrido, Ana, García‐Fortes, María, de Miguel Llorente, Dunia, Leonardo, Anastasia Aules, Cervero, Carlos, Jordá, Rosa Coll, Pérez‐Encinas, Manuel M., Zarzuela, Marta Polo, Figuera, Angela, Rad, Guillermo, Martínez‐Cuadrón, David, Montesinos, Pau

“…Background CPX‐351 is approved for the treatment of therapy related acute myeloid leukemia (t‐AML) and AML with myelodysplastic related changes (MRC‐AML). The…”
Get full text

Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study by Dachs, Laura Rosiñol, Gaisán, Carmen Montes, Bustamante, Gabriela, López, Sebastián Garzón, García, Esther González, Persona, Ernesto Pérez, González-Calle, Verónica, Auzmendi, Maialen Sirvent, Pérez, José Maria Arguiñano, González Montes, Yolanda, Ríos Tamayo, Rafael, de Miguel Llorente, Dunia, Bernal, Luis Palomera, Mayol, Antonia Sampol, Caro, Carmen Couto, Grande, Marta, Fernández-Nistal, Alonso, Naves, Andrea, Miguel, Enrique M Ocio San

“…We evaluated the psychometric properties of the Spanish version of the European Organization for Research and Treatment of Multiple Myeloma (MM) specific…”
Get full text

Impact of early palliative care intervention in autologous bone marrow transplantation: feasibility of a multicentric study by Argüello-Marina, María, Callejas-Charavía, Marta, Merchán-Muñoz, Beatriz, Gainza-Miranda, Daniel, Rico-Zampetti, Agustina, Pérez-Maganto, Raquel, Ruiz-Ares, Gustavo, García-Ramírez, Patricia, de Miguel-Llorente, Dunia, García-Suárez, Julio

“…This prospective multicentre study evaluates the impact of Palliative Care Unit (PCU) intervention (Experimental Group, EG), during autologous hematopoietic…”
Get full text

PB2703: ISA‐KD IN NOT TRANSPLANT CANDIDATES RRMM. EXPERIENCE IN REAL LIFE by Llorente, Dunia De Miguel, Lopez, Nuria Golbano, Alonso, Rocio Perez, Ramo, Alejandro Vazquez, Montero, Ana Belen Santos, Lopez, Irene Nuevo, Argumanez, Marta Mora, Garcia, Helga Guillen, Perez, Angela Gil

Get full text

PB2491: LANGERHANS CELL HISTIOCYTOSIS (LCH) IN THE MAXILLOFACIAL AREA IN ADULT. COMPLETE REMISSION WITH CLADRIBINE. CASE REPORT AND REVIEW by De Miguel Llorente, Dunia, Golbano López, Nuria, Belen Santos Montero, Ana, Alonso, Rocio Perez, Vazquez Ramo, Alejandro, Guillen García, Helga, Gil Perez, Angela, Mora Argumanez, Marta, Nuevo Lopez, Irene

Get full text

PB2628: EXPERIENCE AT THE GUADALAJARA UNIVERSITY HOSPITAL (SPAIN) IN FETAL AND NEONATAL ALLOINMUNE THROMBOCYTOPENIA (FNAIT) DURING EIGHT YEARS by López, María Irene Nuevo, Argumanez, Marta Mora, Sanz, Mª Dolores Morales, Alonso, Rocio Perez, Padilla, Beatriz Álvarez, Pérez, Ángela Gil, García, Helga Guillén, Ramo, Alejandro Vazquez, Fernandez, Berta Mercedes Michael, López, Nuria Golbano, Herrero, Sonia, Juanis, Jaime Arbeteta, Llorente, Dunia de Miguel

Get full text

PB2270: PROGNOSTIC VALUE OF INTERIM POSITRON EMISSION TOMOGRAPHY IN HIGH‐TUMOR‐BURDEN FOLLICULAR LYMPHOMA by Argumánez, Marta Mora, Perez, Rocio, Padilla, Beatriz Alvarez, López, María Irene Nuevo, Gil, Angela, Pérez, Dolores Subirá, Montero, Ana Belén Santos, Golbano, Nuria, García, Helga Guillén, Ramo, Alejandro Vazquez, Martín, Sonia Herrero, Moreno, Laura, Juanis, Jaime Arbeteta, Sanz, María Dolores Morales, Llorente, Dunia De Miguel

Get full text

Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma by Perez, Cristina, Botta, Cirino, Zabaleta, Aintzane, Puig, Noemi, Cedena, Maria-Teresa, Goicoechea, Ibai, Alameda, Daniel, San José-Eneriz, Edurne, Merino, Juana, Rodríguez-Otero, Paula, Maia, Catarina, Alignani, Diego, Maiso, Patricia, Manrique, Irene, Lara-Astiaso, David, Vilas-Zornoza, Amaia, Sarvide, Sarai, Riillo, Caterina, Rossi, Marco, Rosiñol, Laura, Oriol, Albert, Blanchard, María-Jesús, Rios, Rafael, Sureda, Anna, Martin, Jesus, Martinez, Rafael, Bargay, Joan, de la Rubia, Javier, Hernandez, Miguel-Teodoro, Martinez-Lopez, Joaquin, Orfao, Alberto, Agirre, Xabier, Prosper, Felipe, Mateos, Maria-Victoria, Lahuerta, Juan-José, Blade, Joan, San-Miguel, Jesús F., Paiva, Bruno

“…Granulocytic myeloid-derived suppressor cells (G-MDSCs) promote tumor growth and immunosuppression in multiple myeloma (MM). However, their phenotype is not…”
Get full text

Efficacy and Safety of Fostamatinib for Immune Thrombocytopenia in Clinical Practice in Spain: Interim Results of Fostames, Our National Fostamatinib Registry by Gonzalez-Lopez, Tomas Jose, Perez Segura, Gloria, Domingo, Abel, Lopez Ansoar, Elsa, Diaz Galvez, Francisco Javier, Jimenez Barcenas, Reyes, Martinez Carballeira, Daniel, De Miguel Llorente, Dunia, Perona Blazquez, Alvaro, Aguilar-Monserrate, Gerardo, Dávila-Valls, Julio, Gonzalez Gascon, Isabel, Cuesta, Amalia, Bengochea Casado, María Luisa, Hermida Fernandez, Gerardo Julio, Alonso Alonso, Jose Maria, Pozas Mañas, Miguel Angel, Torres-Tienza, Ana, Aguilar, Carlos, Fernandez-Jimenez, Dolores, Soto, Inmaculada, Bernat, Silvia

“…Background: Fostamatinib is a splenic tyrosine kinase (SYK) inhibitor that prevents antibody-mediated platelet destruction. This drug has demonstrated to be…”
Get full text

Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice by González-López, Tomás José, Bermejo-Vega, Nuria, Cardesa-Cabrera, Rocío, Martínez-Robles, Violeta, Aguilar-Monserrate, Gerardo, Pérez-Segura, Gloria, Domingo, Abel, Luis-Navarro, Josefa, Lakhwani, Sunil, Acedo, Natalia, Lozano, María Luisa, Bernat, Silvia, Torres-Tienza, Ana, Ruano, Ana, Jarque, Isidro, Galán, Pilar, Benet, Carmen, Marcellini, Shally, Jimenez-Bárcenas, Reyes, Martínez-Carballeira, Daniel, De Miguel-Llorente, Dunia, Perona-Blázquez, Alvaro, Gonzalez-Gascón, Isabel, Lopez-Ansoar, Elsa, Alonso-Alonso, José María, Bengochea-Casado, María Luisa, Díaz-Gálvez, Francisco Javier, Moretó, Ana, Moreno-Jiménez, Gemma, Hernández-Martin, Roberto, de Cabo, Erik, Dávila-Valls, Julio, Cuesta, Amalia, Pastoriza, Carmen, Hermida-Fernández, Gerardo Julio, García, Covadonga, Pozas-Mañas, Miguel Angel, Aguilar, Carlos, Fernandez-Jimenez, Dolores, Navas-Elorza, Begoña, López-Santamaría Castro, Carolina, Lorenzo, Alvaro, Ortín, Xavier, García, Marta, Piernas, Sonia, Díaz-Santa, Johana, Soto, Inmaculada, Provan, Drew, García-Donas Gabaldón, Gloria

“…•Similar to clinical trial results, fostamatinib has demonstrated a high efficacy rate for ITP in daily clinical practice conditions.•Fostamatinib is a…”
Get full text

Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group by Palanques-Pastor, Tomás, Megías-Vericat, Juan Eduardo, Martínez, Pilar, López Lorenzo, José Luis, Cornago Navascués, Javier, Rodriguez Macias, Gabriela, Cano, Isabel, Arnan Sangerman, Montserrat, Vidriales Vicente, María Belén, Algarra Algarra, Jesús Lorenzo, Foncillas, María Ángeles, Herrera, Pilar, Botella Prieto, Carmen, Vives, Susana, Figuera Álvarez, Ángela, Cuevas Palomares, Laida, Sobas, Marta, Contento Gonzalo, Alejandro, Cuello García, Rebeca, Amutio Diez, María Elena, De Miguel Llorente, Dunia, Navas Elorza, Begoña, Bergua Burgues, Juan Miguel, Bernal Del Castillo, Teresa, Mateos Rodríguez, María Carmen, de Cabo López, Erik, Franco Villegas, Ana Carolina, García Boyero, Raimundo, Escolano Escobar, Cristian, Seri Merino, Cristina, Cervero, Carlos, Roldán Pérez, Alicia, Hermosín Ramos, Lourdes, Cervera Calvo, Marta, Olave, María Telesa, Villafuerte Gutiérrez, Paola, de Laiglesiai, Almudena, Serrano, Josefina, Najera Irazu, María Josefa, Piñana, José Luis, Sanz, Miguel Ángel, Martínez-López, Joaquín, Montesinos, Pau

“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection produces higher morbidity and mortality in hematological malignancies, but evidence in…”
Get full text

Clinical Experience with Azacitidine In Secondary Myelodysplastic Syndrome In Spain by García, Regina, Sanz, Guillermo F, Llorente, Dunia de Miguel, Nomdedeu, Benet, Romero, M Mar, Bernal, Teresa, Besalduch, Juan, Amutio, Elena, Brunet, Salut, de Smd, Grupo Andaluz

“…Abstract 1852 Secondary myelodysplastic syndromes (MDS) and acute leukemias are some of the most serious adverse side effects in the treatment with…”
Get full text

Azacitidine In Compassionate Use: Response to Therapy, Survival, and Prognostic Factors In 200 Patients Diagnosed with MDS or AML by García, Regina, de Miguel LLorente, Dunia, Bargay, Joan, Bernal, Teresa, González Porras, Jose Ramón, Tormo, Mar, Ramos, Fernando, Lapiedra, Andreu, Falantes, Jose, Xicoy, Blanca, Sanz, Guillermo F, Nomdedeu, Benet, Brunet, Salut, Sánchez, Joaquín

“…Abstract 2933 Survival analysis need of large period of time for getting results. Survival subrogates variables provide with earlier data for clinical…”
Get full text